HuagongsheHuagongshe Chemistry Print Report · For research reference only
6-{[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl}quinoline → 3-(1h-Indazol-5-ylmethyl)-6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6-{[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl}quinoline | HCID 44206063 | — |
| Reactant | (Rac)-(1h-indazol-5-yl)-[6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazin-3-yl]-methanol | HCID 69076952 | — |
| Product | 3-(1h-Indazol-5-ylmethyl)-6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazine | HCID 57917270 | — |
Reaction Steps
The title compound was prepared in analogy to the synthesis of compound of Example 2 using (rac)-(1H-Indazol-5-yl)-[6-(1-methyl-1H-pyrazol-4-yl)-imidazo[1,2-b]pyridazin-3-yl]-methanol (Stage 150.1) as starting material (tR 1.10 min (conditions 2), MH+=330).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08822468B2 |
| Source dataset | uspto-grants-2014_09 |
| ORD ID | ord-4b5ee10456664d87b3a852c4e9a3f085 |
| Source note | uspto-grants-2014_09 |